This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Maat Pharma. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Emilie Plantamura: Innovator in Fecal Microbiota Research
Introduction
Emilie Plantamura is a notable inventor based in Lyons, France. He has made significant contributions to the field of microbiota research, particularly in the context of treatment-induced inflammation. His innovative work has the potential to impact the medical community and improve patient outcomes.
Latest Patents
Emilie Plantamura holds 1 patent for his invention titled "Fecal microbiota composition for use in reducing treatment-induced inflammation." This invention relates to the use of fecal microbiota transplant to prevent and/or reduce systemic and gut treatment-induced inflammation in individuals in need of such intervention.
Career Highlights
Emilie is currently associated with Maat Pharma, a company focused on developing microbiota-based therapies. His work at Maat Pharma has positioned him as a key player in the advancement of microbiota research and its applications in medicine.
Collaborations
Emilie has collaborated with notable colleagues, including Cyrielle Gasc and Benoît Levast. These collaborations have further enriched his research and contributed to the development of innovative solutions in the field.
Conclusion
Emilie Plantamura's contributions to fecal microbiota research exemplify the importance of innovation in addressing medical challenges. His work not only highlights the potential of microbiota therapies but also underscores the collaborative spirit within the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile